Bloomage BioTechnology Corporation Limited (SHA: 688363)
China
· Delayed Price · Currency is CNY
60.10
-0.72 (-1.18%)
Nov 21, 2024, 3:00 PM CST
Bloomage BioTechnology Corporation Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 511.52 | 1,169 | 1,606 | 1,807 | 1,390 | 2,201 | Upgrade
|
Short-Term Investments | - | - | - | - | - | 800.7 | Upgrade
|
Trading Asset Securities | 30.03 | 140.04 | 530.72 | 846.89 | 722.7 | - | Upgrade
|
Cash & Short-Term Investments | 541.55 | 1,309 | 2,137 | 2,654 | 2,113 | 3,002 | Upgrade
|
Cash Growth | -54.77% | -38.75% | -19.47% | 25.58% | -29.62% | 251.57% | Upgrade
|
Accounts Receivable | 532.95 | 450.19 | 457.87 | 402.22 | 388.99 | 393.48 | Upgrade
|
Other Receivables | 53.18 | 39.42 | 51.91 | 28.9 | 34.7 | 7.46 | Upgrade
|
Receivables | 586.14 | 489.61 | 509.78 | 431.12 | 423.69 | 400.94 | Upgrade
|
Inventory | 1,315 | 1,135 | 1,162 | 709.13 | 476.77 | 314.51 | Upgrade
|
Other Current Assets | 239.52 | 189.99 | 214.93 | 190.37 | 650.11 | 53.08 | Upgrade
|
Total Current Assets | 2,682 | 3,123 | 4,023 | 3,984 | 3,664 | 3,771 | Upgrade
|
Property, Plant & Equipment | 4,190 | 3,657 | 2,913 | 2,305 | 1,258 | 658.3 | Upgrade
|
Long-Term Investments | 521.72 | 502.99 | 592.63 | 400.32 | 17.9 | 15.03 | Upgrade
|
Goodwill | 250.97 | 251.28 | 247.22 | 67.15 | 74.64 | 72.69 | Upgrade
|
Other Intangible Assets | 488.65 | 496.97 | 475.06 | 467.26 | 426.74 | 385.48 | Upgrade
|
Long-Term Deferred Tax Assets | 330.54 | 336.98 | 302.59 | 246.11 | 93 | 42.89 | Upgrade
|
Long-Term Deferred Charges | 89.1 | 98.14 | 116.43 | 31.85 | 15.64 | 18.91 | Upgrade
|
Other Long-Term Assets | 134.59 | 3.63 | 11.5 | 1.44 | 167.32 | 7.68 | Upgrade
|
Total Assets | 8,688 | 8,470 | 8,682 | 7,504 | 5,717 | 4,972 | Upgrade
|
Accounts Payable | 787.4 | 186.78 | 247.75 | 243.55 | 119.08 | 53.31 | Upgrade
|
Accrued Expenses | 115.91 | 479.49 | 672.75 | 704.09 | 236.64 | 204.26 | Upgrade
|
Short-Term Debt | - | - | 139.2 | - | 24.08 | - | Upgrade
|
Current Portion of Long-Term Debt | 34.1 | 106.08 | 36.54 | 36.46 | - | - | Upgrade
|
Current Portion of Leases | - | 47.05 | 53.67 | 49.61 | - | - | Upgrade
|
Current Income Taxes Payable | 72.85 | 55.68 | 76.43 | 135.52 | 50.91 | 41.58 | Upgrade
|
Current Unearned Revenue | 77.48 | 55.58 | 67.74 | 50.83 | 43.4 | 19.62 | Upgrade
|
Other Current Liabilities | 48.49 | 290.13 | 349.97 | 180.46 | 78.77 | 46.93 | Upgrade
|
Total Current Liabilities | 1,136 | 1,221 | 1,644 | 1,401 | 552.87 | 365.7 | Upgrade
|
Long-Term Debt | 92.86 | 2.32 | 107.97 | 144.18 | - | - | Upgrade
|
Long-Term Leases | 175.07 | 52.66 | 52.42 | 69.77 | - | - | Upgrade
|
Long-Term Unearned Revenue | 227.17 | 205.73 | 188.68 | 182.71 | 141.35 | 51.8 | Upgrade
|
Long-Term Deferred Tax Liabilities | 3.42 | 5.09 | 5.66 | 4.12 | 4.54 | 4.61 | Upgrade
|
Total Liabilities | 1,635 | 1,487 | 1,999 | 1,801 | 698.76 | 422.11 | Upgrade
|
Common Stock | 481.68 | 481.68 | 481.09 | 480 | 480 | 480 | Upgrade
|
Additional Paid-In Capital | 3,851 | 3,841 | 3,753 | 3,569 | 3,452 | 3,452 | Upgrade
|
Retained Earnings | 2,888 | 2,708 | 2,409 | 1,674 | 1,088 | 620 | Upgrade
|
Treasury Stock | -219.95 | -105.88 | - | - | - | - | Upgrade
|
Comprehensive Income & Other | 17.71 | 19.57 | -9.1 | -23.91 | -0.01 | -1.19 | Upgrade
|
Total Common Equity | 7,019 | 6,944 | 6,634 | 5,699 | 5,020 | 4,550 | Upgrade
|
Minority Interest | 34.44 | 39.33 | 49.21 | 3.45 | -1.62 | -0.79 | Upgrade
|
Shareholders' Equity | 7,053 | 6,983 | 6,683 | 5,702 | 5,018 | 4,550 | Upgrade
|
Total Liabilities & Equity | 8,688 | 8,470 | 8,682 | 7,504 | 5,717 | 4,972 | Upgrade
|
Total Debt | 302.03 | 208.1 | 389.79 | 300.01 | 24.08 | - | Upgrade
|
Net Cash (Debt) | 239.52 | 1,101 | 1,747 | 2,354 | 2,089 | 3,002 | Upgrade
|
Net Cash Growth | -76.01% | -37.00% | -25.77% | 12.67% | -30.42% | 268.85% | Upgrade
|
Net Cash Per Share | 0.50 | 2.28 | 3.62 | 4.87 | 4.37 | 6.87 | Upgrade
|
Filing Date Shares Outstanding | 478.36 | 480.26 | 481.09 | 480 | 480 | 480 | Upgrade
|
Total Common Shares Outstanding | 478.36 | 480.26 | 481.09 | 480 | 480 | 480 | Upgrade
|
Working Capital | 1,546 | 1,902 | 2,379 | 2,584 | 3,111 | 3,405 | Upgrade
|
Book Value Per Share | 14.67 | 14.46 | 13.79 | 11.87 | 10.46 | 9.48 | Upgrade
|
Tangible Book Value | 6,279 | 6,196 | 5,911 | 5,165 | 4,518 | 4,092 | Upgrade
|
Tangible Book Value Per Share | 13.13 | 12.90 | 12.29 | 10.76 | 9.41 | 8.53 | Upgrade
|
Buildings | - | 1,756 | 1,385 | 1,269 | 458.14 | 352.2 | Upgrade
|
Machinery | - | 1,410 | 1,148 | 812.35 | 495.06 | 397.54 | Upgrade
|
Construction In Progress | - | 1,109 | 830.45 | 516.72 | 618.11 | 171.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.